E Brummer

Author PubWeight™ 79.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect Immun 1985 1.82
2 In vitro lymphocyte responses of coccidioidin skin test-positive and -negative persons to coccidioidin, spherulin, and a coccidioides cell wall antigen. Infect Immun 1977 1.69
3 Comparison of fluconazole and ketoconazole in experimental murine blastomycosis. Rev Infect Dis 1990 1.61
4 Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob Agents Chemother 1994 1.41
5 Comparison of various techniques for determining viability of Paracoccidioides brasiliensis yeast-form cells. J Clin Microbiol 1982 1.35
6 Macrophages and fungi: in vitro effects of method of macrophage induction, activation by different stimuli, and soluble factors on Blastomyces. J Reticuloendothel Soc 1980 1.31
7 Virulence of fungi: correlation of virulence of Blastomyces dermatitidis in vivo with escape from macrophage inhibition of replication in vitro. Infect Immun 1981 1.25
8 A microculture system for the measurement of antigen-induced murine lymphocyte proliferation: advantages of 5% horse serum and 5 X 10(-5) M mercaptoethanol. J Immunol Methods 1977 1.25
9 A culture medium for Paracoccidioides brasiliensis with high plating efficiency, and the effect of siderophores. J Med Vet Mycol 1988 1.20
10 Activity of ICI 195,739, a new oral triazole, compared with that of ketoconazole in the therapy of experimental murine blastomycosis. Antimicrob Agents Chemother 1989 1.19
11 Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Antimicrob Agents Chemother 1998 1.17
12 Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhance fluconazole activity. Antimicrob Agents Chemother 1995 1.16
13 In vivo and in vitro cell-mediated responses in coccidioidomycosis. I. Immumologic responses of persons with primary, asymptomatic infections. Am Rev Respir Dis 1976 1.16
14 Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing of Candida species. J Infect Dis 1995 1.15
15 Activation of murine polymorphonuclear neutrophils for fungicidal activity by recombinant gamma interferon. J Leukoc Biol 1987 1.13
16 Treatment of paracoccidioidomycosis with itraconazole in a murine model. J Trop Med Hyg 1985 1.11
17 Efficacy of itraconazole in blastomycosis in a murine model and comparison with ketoconazole. Mycoses 1989 1.09
18 Influence of human sera on the in vitro activity of the echinocandin caspofungin (MK-0991) against Aspergillus fumigatus. Antimicrob Agents Chemother 2000 1.08
19 Activities of the modified polyene N-D-ornithyl amphotericin methyl ester and the azoles ICI 153066, Bay n 7133, and Bay l 9139 compared with those of amphotericin B and ketoconazole in the therapy of experimental blastomycosis. Antimicrob Agents Chemother 1985 1.06
20 The interaction of human monocytes, monocyte-derived macrophages, and polymorphonuclear neutrophils with caspofungin (MK-0991), an echinocandin, for antifungal activity against Aspergillus fumigatus. Diagn Microbiol Infect Dis 2001 1.06
21 Role of extended culture time on synergy of fluconazole and human monocyte-derived macrophages in clearing Candida albicans. J Infect Dis 1996 1.04
22 Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen. Infect Immun 1999 1.04
23 An evaluation of the enzyme-linked immunoabsorbent assay (ELISA) for quantitation of antibodies to Paracoccidioides brasiliensis. J Med Vet Mycol 1986 1.04
24 Strain differences in resistance to infection reversed by route of challenge: studies in blastomycosis. Infect Immun 1981 1.03
25 Protection against pulmonary blastomycosis: correlation with cellular and humoral immunity in mice after subcutaneous nonlethal infection. Infect Immun 1982 1.01
26 Chronic pulmonary and disseminated paracoccidioidomycosis in mice: quantitation of progression and chronicity. J Med Vet Mycol 1987 0.98
27 Immunological activation of polymorphonuclear neutrophils for fungal killing: studies with murine cells and blastomyces dermatitidis in vitro. J Leukoc Biol 1984 0.98
28 Support of Paracoccidioides brasiliensis multiplication by human monocytes or macrophages: inhibition by activated phagocytes. J Med Microbiol 1994 0.97
29 Treatment of Mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans? J Infect Dis 1996 0.96
30 Murine pulmonary macrophages: evaluation of lung lavage fluids, miniaturized monolayers, and candidacidal activity. Am Rev Respir Dis 1983 0.95
31 Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole. J Med Microbiol 1998 0.95
32 Susceptibility of Blastomyces dermatitidis strains to products of oxidative metabolism. Infect Immun 1983 0.95
33 Fungicidal activity of murine inflammatory polymorphonuclear neutrophils: comparison with murine peripheral blood PMN. Clin Exp Immunol 1986 0.94
34 Effect of iron on fluconazole activity against Candida albicans in presence of human serum or monocyte-derived macrophages. Mycopathologia 1997 0.94
35 Enhanced oxidative burst in immunologically activated but not elicited polymorphonuclear leukocytes correlates with fungicidal activity. Infect Immun 1985 0.94
36 Opposite effects of human monocytes, macrophages, and polymorphonuclear neutrophils on replication of Blastomyces dermatitidis in vitro. Infect Immun 1982 0.93
37 Inhibitory effect of deferoxamine or macrophage activation on transformation of Paracoccidioides brasiliensis conidia ingested by macrophages: reversal by holotransferrin. Infect Immun 1994 0.92
38 Impairment of cellular but not humoral immune responses in chronic pulmonary and disseminated paracoccidioidomycosis in mice. Infect Immun 1988 0.92
39 Activation of murine polymorphonuclear neutrophils for fungicidal activity with supernatants from antigen-stimulated immune spleen cell cultures. Infect Immun 1984 0.92
40 In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing. Infect Immun 1989 0.90
41 Study of current and new drugs in a murine model of acute paracoccidioidomycosis. Am J Trop Med Hyg 1985 0.90
42 Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans. Med Mycol 2002 0.89
43 Antifungal activity of murine polymorphonuclear neutrophils against Histoplasma capsulatum. J Med Vet Mycol 1991 0.89
44 Macrophage colony-stimulating factor (M-CSF) induction of enhanced anticryptococcal activity in human monocyte-derived macrophages: synergy with fluconazole for killing. Cell Immunol 1995 0.88
45 Virulent isolates and mutants of Blastomyces in mice: a legacy for studies of pathogenesis. Semin Respir Infect 1997 0.88
46 Activation of peritoneal macrophages by concanavalin A or Mycobacterium bovis BCG for fungicidal activity against Blastomyces dermatitidis and effect of specific antibody and complement. Infect Immun 1983 0.88
47 Effect of anti-IL-4, interferon-gamma and an antifungal triazole (SCH 42427) in paracoccidioidomycosis: correlation of IgE levels with outcome. Clin Exp Immunol 1993 0.87
48 Fate of conidia of Paracoccidioides brasiliensis after ingestion by resident macrophages or cytokine-treated macrophages. Infect Immun 1992 0.86
49 The iron-hydrogen peroxide-iodide system is fungicidal: activity against the yeast phase of Blastomyces dermatitidis. J Leukoc Biol 1984 0.86
50 Effect of granulocyte colony-stimulating factor on the candidacidal activity of polymorphonuclear neutrophils and their collaboration with fluconazole. Antimicrob Agents Chemother 1997 0.86
51 Protection against pulmonary blastomycosis: adoptive transfer with T lymphocytes, but not serum, from resistant mice. Cell Immunol 1982 0.86
52 Enhancing effect of murine polymorphonuclear neutrophils (PMN) on the multiplication of Blastomyces dermatitidis in vitro and in vivo. Clin Exp Immunol 1983 0.85
53 Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans. Antimicrob Agents Chemother 1994 0.85
54 A method for eliciting indurated DTH reactions to soluble protein antigens in the flank skin of mice: correlation of visual measurements with 125I-UdR uptake indices. Int Arch Allergy Appl Immunol 1981 0.84
55 Fungicidal activity of murine broncho-alveolar macrophages against Blastomyces dermatitidis. J Med Microbiol 1986 0.84
56 Effect of murine polymorphonuclear leukocytes on the yeast form of Paracoccidioides brasiliensis [corrected]. Am J Trop Med Hyg 1987 0.83
57 Killing of Histoplasma capsulatum by macrophage colony stimulating factor-treated human monocyte-derived macrophages: role for reactive oxygen intermediates. J Med Microbiol 1995 0.83
58 Immunostimulation with muramyl dipeptide and its desmethyl analogue: Studies of non-specific resistance to pulmonary blastomycosis in inbred mouse strains. Mycopathologia 1983 0.82
59 Induction of stress protein synthesis in Histoplasma capsulatum by heat, low pH and hydrogen peroxide. J Med Vet Mycol 1992 0.82
60 Effect of a local immune reaction on peripheral blood polymorphonuclear neutrophil microbicidal function: studies with fungal targets. Cell Immunol 1987 0.82
61 Isolation of a human serum protein that inhibits the growth of Cryptococcus neoformans. Mycopathologia 1999 0.82
62 Mechanisms in opposite modulation of spleen cell and lymph node cell responses to mitogens following muramyl dipeptide treatment in vivo. Cell Immunol 1985 0.81
63 Isolation and characterisation of an anticryptococcal protein in human cerebrospinal fluid. J Med Microbiol 2001 0.81
64 Characterization of an anticryptococcal protein isolated from human serum. Infect Immun 2000 0.81
65 Immunoglobulin E antibody formation in response to homologous rabbit albumin heavily substituted with dinitrophenol: effect of adjuvant. Infect Immun 1975 0.81
66 Study of the role of iron in the anticryptococcal activity of human serum and fluconazole. Mycopathologia 1996 0.80
67 Effects of granulocyte-macrophage colony stimulating factor (GM-CSF) in vivo on cytokine production and proliferation by spleen cells. Clin Exp Immunol 2001 0.80
68 Combined treatment: antifungal drugs with antibodies, cytokines or drugs. Med Mycol 2000 0.80
69 Opposite modulation of lymph node cell and spleen cell responses to mitogens by muramyl dipeptide and its desmethyl analog. Cell Immunol 1981 0.80
70 Regulation of immune responses by T suppressor cells and by serum in chronic paracoccidioidomycosis. Cell Immunol 1988 0.80
71 Resistance of Histoplasma capsulatum to killing by human neutrophils. Evasion of oxidative burst and lysosomal-fusion products. Mycopathologia 1991 0.80
72 Biochemical mechanisms of intracellular killing of fungi. J Med Vet Mycol 1992 0.79
73 Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Antimicrob Agents Chemother 1998 0.79
74 Treatment of Myocardium avium complex infection: does the beige mouse model predict therapeutic outcome in humans? J Infect Dis 1996 0.79
75 Chronic murine paracoccidioidomycosis: effect of ketoconazole on clearance of Paracoccidioides brasiliensis and immune response. Sabouraudia 1984 0.79
76 Killing of Paracoccidioides brasiliensis conidia by pulmonary macrophages and the effect of cytokines. J Med Vet Mycol 1992 0.79
77 Synergy of fluconazole with macrophages for antifungal activity against Candida albicans. Mycopathologia 1996 0.79
78 Immunomodulation in mycoses. J Med Vet Mycol 1994 0.78
79 Interaction of subpopulations of murine lymph node lymphocytes in antigen-induced [14C]-thymidine incorporation: T and B cell synergy in the response to antigen. Immunology 1979 0.78
80 Toxic effect of products of oxidative metabolism on the yeast form of Paracoccidioides brasiliensis. J Med Microbiol 1984 0.77
81 Fungicidal activity of human peripheral blood leukocytes against Paracoccidioides brasiliensis yeast cells. Med Mycol 2005 0.77
82 Development of antigen-induced proliferative responsiveness by murine lymph node cells. I. Identification of differences in the in vitro proliferative responses during a first and a second period of responsiveness. Immunology 1979 0.77
83 Correlation of susceptibility of immature mice to fungal infection (blastomycosis) and effector cell function. Infect Immun 2000 0.75
84 Induction of novel protein synthesis by opsonized Histoplasma capsulatum ingested by murine peritoneal macrophages. Mycopathologia 1995 0.75
85 Animal models for fungal infections: an update. Mycopathologia 2001 0.75
86 Synergistic antifungal effect of fluconazole and human polymorphonuclear leukocytes on Paracoccidioides brasiliensis: effect of interferon-gamma and granulocyte-macrophage colony-stimulating factor. Med Mycol 2003 0.75
87 In vivo and in vitro effects of macrophage colony-stimulating factor (M-CSF) on bronchoalveolar macrophages for antihistoplasmal activity. Int J Immunopharmacol 1995 0.75